PPP1CA and hepatocellular carcinoma: Our research not only contributes to understanding the biological function of PP1A as a potential therapeutic target but also may provide theoretical support for its use as a new molecular target for the development of combined treatment strategies involving Lenvatinib and ICIs in HCC.